31 May 2021
The ISSCR has released updated guidelines for stem cell research and clinical translation of stem cell-based therapies.
The International Society for Stem Cell Research (ISSCR) has released updated guidelines for stem cell research and its translation into medicine. According to ISSCR, the update was necessary to reflect emerging advances including, stem cell-based embryo models, human embryo research, chimeras, organoids and genome editing.
“The 2021 update presents practical advice for oversight of research posing unique scientific and ethical issues for researchers and the public,” stated Dr Robin Lovell-Badge, Chair of the ISSCR Guidelines task force and Senior Group Leader and Head of the Division of Stem Cell Biology and Developmental Genetics at The Francis Crick Institute, UK. “They provide confidence to researchers, clinicians and the public alike that stem cell science can proceed responsibly, ethically and remain responsive to public and patient interests.”
While the guidelines are often thought of as the international standard for scientific and ethical rigor, oversight and transparency in stem cell research, they also provide a basis for the implementation of new regulatory frameworks in countries without existing oversight systems. According to ISSCR, adherence to the guidelines provides assurance that research is conducted with integrity and new therapies are safe, effective and evidence-based.
“This is a significant update, building upon the society’s longstanding commitment to excellence in all areas of stem cell research,” added Dr Christine Mummery, ISSCR president and professor of Developmental Biology at Leiden University Medical Center, the Netherlands. “The updates address new methods of understanding fundamental biological processes that may ultimately lead to the alleviation of debilitating diseases and disorders.”
The 2021 ISSCR Guidelines update is the result of a two-year collaboration with international experts and respected leaders in areas of stem cell science, ethics and law, and was peer-reviewed by scientists and ethicists from 14 countries.
With regards to the development and implementation of stem cell therapies in clinic, there a five key guideline updates:
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024